Helicos Installs Five Sequencers in Q3; Continues Talks with 'Multiple Strategic Parties'

The company said it expects approximately $5 million in cash receipts from previously announced orders and associated reagent purchases during the fourth quarter of this year and the first quarter of 2010.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.